Gene · 8317
Papers1,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aberrant AHRR, ADAMTS2 and FAM184 DNA Methylation: Candidate Biomarkers in the Oral Rinse of Heavy Smokers. | Biomedicines | 2023 | 37509437 | PubTator, text mining | PubMed |
| Disruption of the Mammalian Ccr4-Not Complex Contributes to Transcription-Mediated Genome Instability. | Cells | 2023 | 37508532 | PubTator, text mining | PubMed |
| ZFP57 promotes ovarian cancer progression by transcriptionally regulating BRCA1 and managing G1 checkpoint. | J Cancer | 2023 | 37497403 | PubTator, text mining | PubMed |
| DBF4 Dependent Kinase Inhibition Suppresses Hepatocellular Carcinoma Progression and Potentiates Anti-Programmed Cell Death-1 Therapy. | Int J Biol Sci | 2023 | 37497004 | PubTator, text mining | PubMed |
| ORC1 binds to cis-transcribed RNAs for efficient activation of replication origins. | Nat Commun | 2023 | 37488096 | PubTator, text mining | PubMed |
| Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer. | Cancer Cell | 2023 | 37478850 | PubTator, text mining | PubMed |
| Multiple suppressing small interfering RNA for cancer treatment-Application to triple-negative breast cancer. | Biotechnol J | 2023 | 37478121 | PubTator, text mining | PubMed |
| A conserved arginine within the αC-helix of Erk1/2 is a latch of autoactivation and of oncogenic capabilities. | J Biol Chem | 2023 | 37474104 | PubTator, text mining | PubMed |
The mirror like expression of genes involved in the FOXO signaling pathway could be effective in the pathogenesis of human lymphotropic virus type 1 (HTLV-1) through disruption of the downstream pathways. | BMC Res Notes | 2023 | 37461070 | PubTator, text mining | PubMed |
| Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis. | Cancer Cell Int | 2023 | 37452331 | PubTator, text mining | PubMed |
| Moonlight functions of glycolytic enzymes in cancer. | Front Mol Biosci | 2023 | 37449059 | PubTator, text mining | PubMed |
| Firing of Replication Origins Is Disturbed by a CDK4/6 Inhibitor in a pRb-Independent Manner. | Int J Mol Sci | 2023 | 37445805 | PubTator, text mining | PubMed |
| Misregulation of cell cycle-dependent methylation of budding yeast CENP-A contributes to chromosomal instability. | Mol Biol Cell | 2023 | 37436802 | PubTator, text mining | PubMed |
| Azaindole derivatives as potential kinase inhibitors and their SARs elucidation. | Eur J Med Chem | 2023 | 37423125 | PubTator, text mining | PubMed |
| Transactive response DNA-binding protein 43 is enriched at the centrosome in human cells. | Brain | 2023 | 37410912 | PubTator, text mining | PubMed |
| Multiplex single-cell chemical genomics reveals the kinase dependence of the response to targeted therapy. | bioRxiv | 2023 | 37398090 | PubTator, text mining | PubMed |
| A novel camptothecin derivative, ZBH-01, exhibits superior antitumor efficacy than irinotecan by regulating the cell cycle. | J Transl Med | 2023 | 37386467 | PubTator, text mining | PubMed |
| PTBP1 enforces ATR-CHK1 signaling determining the potency of CDC7 inhibitors. | iScience | 2023 | 37378325 | PubTator, text mining | PubMed |
| Molecular functions of MCM8 and MCM9 and their associated pathologies. | iScience | 2023 | 37378315 | PubTator, text mining | PubMed |
| Editorial for the IJMS Special Issue on "Molecular Genetics of Autism and Intellectual Disability". | Int J Mol Sci | 2023 | 37373542 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8317/papers?page=7